Cargando…

Resting heart rate (variability) and cognition relationships reveal cognitively healthy individuals with pathological amyloid/tau ratio

INTRODUCTION: Resting heart rate (HR) and heart rate variability (HRV) have been linked with cognition in the general population and in older individuals. The knowledge of this aspect of heart-brain relationship is relatively absent in older individuals with early Alzheimer’s disease (AD) pathology....

Descripción completa

Detalles Bibliográficos
Autores principales:	Molloy, Cathleen, Choy, Elizabeth H., Arechavala, Rebecca J., Buennagel, David, Nolty, Anne, Spezzaferri, Mitchell R., Sin, Caleb, Rising, Shant, Yu, Jeremy, Al-Ezzi, Abdulhakim, Kleinman, Michael T., Kloner, Robert A., Arakaki, Xianghong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428767/ https://www.ncbi.nlm.nih.gov/pubmed/37587981 http://dx.doi.org/10.3389/fepid.2023.1168847

Ejemplares similares

The connection between heart rate variability (HRV), neurological health, and cognition: A literature review
por: Arakaki, Xianghong, et al.
Publicado: (2023)

Task switching reveals abnormal brain-heart electrophysiological signatures in cognitively healthy individuals with abnormal CSF amyloid/tau, a pilot study
por: Arechavala, Rebecca Johnson, et al.
Publicado: (2021)

Compromised Behavior and Gamma Power During Working Memory in Cognitively Healthy Individuals With Abnormal CSF Amyloid/Tau
por: Rochart, Roger, et al.
Publicado: (2020)

Retinal nerve fiber layer thickness predicts CSF amyloid/tau before cognitive decline
por: Asanad, Samuel, et al.
Publicado: (2020)

Correction: Retinal nerve fiber layer thickness predicts CSF amyloid/tau before cognitive decline
por: Asanad, Samuel, et al.
Publicado: (2020)

CSF tau and β-amyloid as biomarkers for mild cognitive impairment
por: Hampel, Harald, et al.
Publicado: (2004)

Amyloid duration is associated with preclinical cognitive decline and tau PET
por: Koscik, Rebecca L., et al.
Publicado: (2020)

Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline
por: Ossenkoppele, Rik, et al.
Publicado: (2022)

Oh brother, where art tau? Amyloid, neurodegeneration, and cognitive decline without elevated tau
por: McCollum, Lauren E., et al.
Publicado: (2021)

Practice makes imperfect: stronger implicit interference with practice in individuals at high risk of developing Alzheimer’s disease
por: Hung, Shao-Min, et al.
Publicado: (2023)

Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study
por: Hanseeuw, Bernard J., et al.
Publicado: (2019)

Accelerated inflammatory aging in Alzheimer’s disease and its relation to amyloid, tau, and cognition
por: Cullen, Nicholas C., et al.
Publicado: (2021)

Network interdigitations of Tau and amyloid‐beta deposits define cognitive levels in aging
por: Kim, Chan‐Mi, et al.
Publicado: (2021)

Transmission of amyloid-beta and tau pathologies is associated with cognitive impairments in a primate
por: Lam, Suzanne, et al.
Publicado: (2021)

Mesial temporal tau in amyloid-β-negative cognitively normal older persons
por: Krishnadas, Natasha, et al.
Publicado: (2022)

Amyloid-Tau-Neurodegeneration Profiles and Longitudinal Cognition in Sporadic Young-Onset Dementia
por: Vipin, Ashwati, et al.
Publicado: (2022)

Amyloid- β and tau deposition influences cognitive and functional decline in Down syndrome
por: Grigorova, Monika, et al.
Publicado: (2022)

Olfactory identification in subjective cognitive decline and mild cognitive impairment: Association with tau but not amyloid positron emission tomography
por: Risacher, Shannon L., et al.
Publicado: (2017)

Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease
por: Pichet Binette, Alexa, et al.
Publicado: (2022)

Amyloid-β, Tau, and Cognition in Cognitively Normal Older Individuals: Examining the Necessity to Adjust for Biomarker Status in Normative Data
por: Bos, Isabelle, et al.
Publicado: (2018)

Better Identification of Cognitive Decline With Interleukin-2 Than With Amyloid and Tau Protein Biomarkers in Amnestic Mild Cognitive Impairment
por: Liang, Chih-Sung, et al.
Publicado: (2021)

Stronger implicit interference in cognitively healthy older participants with higher risk of Alzheimer's disease
por: Hung, Shao‐Min, et al.
Publicado: (2022)

Analysis of Default Mode Network in Social Anxiety Disorder: EEG Resting-State Effective Connectivity Study
por: Al-Ezzi, Abdulhakim, et al.
Publicado: (2021)

Visual cognition in non-amnestic Alzheimer's disease: Relations to tau, amyloid, and cortical atrophy
por: Putcha, Deepti, et al.
Publicado: (2019)

Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairment
por: Chandra, Avinash, et al.
Publicado: (2019)

Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age
por: Betthauser, Tobey J, et al.
Publicado: (2020)

Plasma markers predict changes in amyloid, tau, atrophy and cognition in non-demented subjects
por: Pereira, Joana B, et al.
Publicado: (2021)

Amyloid-Driven Tau Accumulation on Mitochondria Potentially Leads to Cognitive Deterioration in Alzheimer’s Disease
por: Cuadrado-Tejedor, Mar, et al.
Publicado: (2021)

Distinct effects of beta‐amyloid and tau on cortical thickness in cognitively healthy older adults
por: Harrison, Theresa M., et al.
Publicado: (2020)

Amyloid and tau positive mild cognitive impairment: clinical and biomarker characteristics of dementia progression
por: Wei, Hong-Chun, et al.
Publicado: (2021)

P-tau and neurodegeneration mediate the effect of β-amyloid on cognition in non-demented elders
por: Ma, Ling-Zhi, et al.
Publicado: (2021)

Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition
por: Pontecorvo, Michael J., et al.
Publicado: (2017)

Racial Disparity in Cerebrospinal Fluid Amyloid and Tau Biomarkers and Associated Cutoffs for Mild Cognitive Impairment
por: Garrett, Stephanie L., et al.
Publicado: (2019)

Mild behavioral impairment is associated with β‐amyloid but not tau or neurodegeneration in cognitively intact elderly individuals
por: Lussier, Firoza Z., et al.
Publicado: (2020)

Better stress coping associated with lower tau in amyloid-positive cognitively unimpaired older adults
por: Arenaza-Urquijo, Eider M., et al.
Publicado: (2020)

Corrigendum: Amyloid and tau positive mild cognitive impairment: clinical and biomarker characteristics of dementia progression
Publicado: (2021)

Trait Mindfulness Is Associated With Less Amyloid, Tau, and Cognitive Decline in Individuals at Risk for Alzheimer’s Disease
por: Strikwerda-Brown, Cherie, et al.
Publicado: (2022)

Activated gliosis, accumulation of amyloid β, and hyperphosphorylation of tau in aging canines with and without cognitive decline
por: Hines, Amelia D., et al.
Publicado: (2023)

Associations of rest-activity patterns with amyloid burden, medial temporal lobe atrophy, and cognitive impairment
por: Roh, Hyun Woong, et al.
Publicado: (2020)

The effect of amyloid deposition on longitudinal resting-state functional connectivity in cognitively normal older adults
por: Lin, Chemin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qt0qc8e7jvb9usifja7r0f85k5